Anthony Digiandomenico - Jun 11, 2025 Form 4 Insider Report for ENDRA Life Sciences Inc. (NDRA)

Role
Director
Signature
/s/ Anthony DiGiandomenico by Mark Busch, attorney-in-fact
Stock symbol
NDRA
Transactions as of
Jun 11, 2025
Transactions value $
$0
Form type
4
Date filed
7/1/2025, 06:25 AM
Previous filing
May 27, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
DIGIANDOMENICO ANTHONY Director C/O ENDRA LIFE SCIENCES INC., 3600 GREEN COURT, SUITE 350, ANN ARBOR /s/ Anthony DiGiandomenico by Mark Busch, attorney-in-fact 2025-07-01 0001083544

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NDRA Common Stock Award $0 +5.38K +9125.42% $0.00 5.44K Jun 11, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 11, 2026.